GLS in Philadelphia-negative and JAK2 V617F-driven myeloproliferative neoplasms (MPNs).

被引:0
|
作者
Ciboddo, Michele
Yan, George
Coen, Chad
Dowgielewicz, Jonathan
Blaylock, Hunter
Arellano, Nicole S.
Zawieracz, Katarzyna
Rosencrance, Alex
Casetti, Ilaria C.
Borsani, Oscar
Catricala, Silvia
Vanni, Daniele
Saygin, Caner
McNerney, Megan
Faubert, Brandon
Pietra, Daniela
Rumi, Elisa
Elf, Shannon Elizabeth
机构
[1] Univ Chicago, Chicago, IL 60616 USA
[2] Policlin San Matteo, Pavia, Italy
[3] Univ Pavia, Pavia, Italy
[4] Fdn IRCCS Policlin San Matteo, Pavia, Italy
[5] IRCCS Policlin San Matteo, Pavia, Italy
[6] IRCCS Policlin S Matteo, Pavia, Italy
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
e15092
引用
收藏
页数:1
相关论文
共 50 条
  • [31] Evaluation of V617F mutation of JAK2 in negative chromosome Philadelphia chronic myeloproliferative disorders
    Remacha, Angel F.
    Puget, Guiomar
    Nomdedeu, Josep F.
    Estivill, Camino
    Pilar Sarda, M.
    Canals, Carme
    MEDICINA CLINICA, 2006, 127 (16): : 601 - 604
  • [32] The Association Between JAK2V617F Mutation and Bone Marrow Fibrosis at Diagnosis in Patients with Philadelphia-Negative Chronic Myeloproliferative Neoplasms
    Ar, M. Cem
    Buyuktas, Deram
    Eskazan, A. Emre
    Aydin, Seniz Ongoren
    Tanrikulu, Eda
    Baslar, Zafer
    Buyru, A. Nur
    Ferhanoglu, Burhan
    Aydin, Yildiz
    Tuzuner, Nukhet
    Soysal, Teoman
    TURKISH JOURNAL OF HEMATOLOGY, 2012, 29 (03) : 242 - 247
  • [33] Targeting PAR1 activation in JAK2V617F-driven philadelphia-negative myeloproliferative neoplasms: Unraveling its role in thrombosis and disease progression
    Uslu-bicak, Ildeniz
    Nalcaci, Meliha
    Soezer, Selcuk
    NEOPLASIA, 2025, 63
  • [34] JAK2 V617F Impairs Lymphoid Differentiation in Myeloproliferative Neoplasms
    Choi, Daniel C.
    Abu-Zeinah, Ghaith
    Kermani, Pouneh
    Messali, Nassima
    Yabut, Maria Mia
    Erdos, Katie
    Scandura, Joseph M.
    BLOOD, 2023, 142
  • [35] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
    Tanja Belcic Mikic
    Tadej Pajic
    Matjaz Sever
    Scientific Reports, 9
  • [36] CALR mutations in a cohort of JAK2 V617F negative patients with suspected myeloproliferative neoplasms
    Mikic, Tanja Belcic
    Pajic, Tadej
    Sever, Matjaz
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [37] A Multiplex Snapback Primer System for the Enrichment and Detection of JAK2 V617F and MPL W515L/K Mutations in Philadelphia-Negative Myeloproliferative Neoplasms
    Wu, Zhiyuan
    Zhang, Yunqing
    Zhang, Xinju
    Xu, Xiao
    Kang, Zhihua
    Li, Shibao
    Zhang, Chen
    Su, Bing
    Guan, Ming
    BIOMED RESEARCH INTERNATIONAL, 2014, 2014
  • [38] Classical Philadelphia-negative myeloproliferative neoplasms (MPNs): A continuum of different disease entities
    Coltro, Giacomo
    Loscocco, Giuseppe G.
    Vannucchi, Alessandro M.
    CELLULAR AND MOLECULAR ASPECTS OF MYELOPROLIFERATIVE NEOPLASMS - PT A, 2021, 365 : 1 - 69
  • [39] Probable HLA-mediated immunoediting of JAK2 V617F-driven oncogenesis
    Ivanova, Milena
    Tsvetkova, Gergana
    Lukanov, Tsvetelin
    Stoimenov, Angel
    Hadjiev, Evgueniy
    Shivarov, Velizar
    EXPERIMENTAL HEMATOLOGY, 2020, 92 : 75 - +
  • [40] THROMBOEMBOLIC AND HEMORRHAGIC COMPLICATIONS AND JAK2 V617F MUTATION POSITIVITY IN PHILADELPHIA NEGATIVE MYELOPROLIFERATIVE DISEASES
    Unubol, M.
    Yavsoglu, I.
    Bozkurt, G.
    Kadikoylu, G.
    Bolaman, Z.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2009, 94 : 590 - 590